mosaiques diagnostics GmbH (SME) is established in Hannover, Germany
The company’s core competence is the early and reliable detection of diseases enabling personalized medicine
during therapy and drug development. The company utilizes diagnostic polypeptide patterns derived from the
fast and accurate analysis of proteins and polypeptides in body fluids (e.g. urine, bile and cerebrospinal fluid).
Mosaiques Diagnostics GmbH has developed and is the leading specialist in clinical proteome and CE-MS analysis,
currently the best technology available for identifying disease-specific polypeptide biomarkers in body fluids.
MOS has published over 120 papers in peer-reviewed journals on its proprietary technology with more than 4,500
citations and filed over 100 patent applications, further underlining the leading role of this European SME.
MOS has developed proprietary hardware for analysis and software solutions for data evaluation, and owns
a unique and proprietary database of peptides in human body fluids of currently 50,000 samples.
MOS has ample experience in clinical studies, and is engaged in collaborative projects with regulatory agencies.
In addition, MOS has filed for qualification of multiparametric proteomics-based classifiers as
biomarkers for human disease with the relevant regulatory agencies (EMA and FDA).